Cannara Biotech Inc. (TSXV:LOVE)

Market Cap	164.75M +119.0%
Revenue (ttm)	112.25M +28.5%
Net Income	11.81M +77.9%
EPS	0.12 +61.6%
Shares Out	95.78M
PE Ratio	14.43
Forward PE	10.12
Dividend	n/a
Ex-Dividend Date	n/a

Volume	71,559
Average Volume	60,095
Open	1.770
Previous Close	1.750
Day's Range	1.690 - 1.780
52-Week Range	1.030 - 2.070
Beta	0.32
RSI	40.93
Earnings Date	Jan 26, 2026

About Cannara Biotech

Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivative products in Canada. The company operates in two segment Cannabis operations and Real estate operations. It offers its products under TRIBAL, nugz, and ORCHID CBD brand name. The company sells its products through wholesalers and online merchandisers. In addition, it engages in the real estate operations. Cannara Biotech Inc. was incorporated in 2017 and is headquartered in Saint-Laurent, Canada.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2017
• Employees: 452
• Stock Exchange: TSX Venture Exchange
• Ticker Symbol: LOVE

Financial Performance

In fiscal year 2025, Cannara Biotech's revenue was 107.20 million, an increase of 31.14% compared to the previous year's 81.75 million. Earnings were 13.08 million, an increase of 103.09%.